Fosun International LTD Neurocrine Biosciences Inc Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $9.92 Million - $12 Million	-118,323 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $1.23 Million - $1.55 Million	17,000 Added 16.78%	118,323 $9.75 Million
Q1 2019 May 10, 2019	BUY	$69.31 - $91.53 $2.7 Million - $3.57 Million	39,000 Added 62.58%	101,323 $8.67 Million
Q4 2018 Jan 31, 2019	BUY	$68.32 - $124.36 $1.31 Million - $2.39 Million	19,223 Added 44.6%	62,323 $4.41 Million
Q3 2018 Nov 09, 2018	BUY	$98.88 - $125.85 $4.26 Million - $5.42 Million	43,100 New	43,100 $5.19 Million

634

94.1M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.